Editing TransMolecular

{{Short description|American biotechnology company}}
{{Infobox company
| name = TransMolecular, Inc.
| industry = [[Biotech]]
| hq_location_city = [[Birmingham, Alabama]]
| parent = Morphotek, Inc. (from 2011)
| website = {{url|transmolecular.com}}
}}

'''TransMolecular''' was a [[biotech]] company located in [[Birmingham, Alabama]]. It was geared to finding anti-[[cancer]] targeted drugs.<ref>{{cite news | title = Hope for brain cancer cure | last = McIntosh | first = Charlotte | work = Birmingham Post-Herald | date = 23 Oct 2000 | page = B1}}</ref>

TransMolecular, Inc. engaged in discovering, developing, and commercializing therapies for [[glioma]], metastatic brain tumors, and cancers.  It developed TM601, a synthetically-produced [[polypeptide]] that was derived from scorpion venom, which is used to specifically target tumors in the treatment of cancer.<ref>{{cite news | title = Scorpion sting may be cure for brain cancer | last = Kowalczyk | first = Liz | date = 30 Jan 1999 | page = 4B | work = The Anniston Star | location = Anniston, Alabama}}</ref>  The company was founded in 1996.  In 2003, Fortune Magazine listed the company as one of the 14 "most exciting, innovative companies in the nation".<ref>{{cite news | title = Technology incubator | last = Centers | first = Jessica | work = The Anniston Star | location = Anniston, Alabama | date = 15 Mar 2004 | page = 1B}}</ref><ref>{{cite web | url = https://money.cnn.com/magazines/fsb/fsb_archive/2003/02/01/336859/ | title = 14 Hot Startups | work = CNN Money | date = 1 Feb 2003 | last1 = Keeney | first1 = Jennifer | last2 = Kwon | first2 = Beth | last3 = Overfelt | first3 = Maggie | accessdate = 21 December 2023}}</ref>

In March 2011, TransMolecular's assets were purchased by Morphotek, a subsidiary of the Japanese pharmaceutical company [[Eisai (company)|Eisai]].<ref>{{cite web | url = https://www.genengnews.com/news/morphotek-acquires-transmoleculars-tumor-targeting-drug-delivery-assets/ | title = Morphotek Acquires TransMolecular's Tumor-Targeting Drug Delivery Assets | work = Genetic Engineering & Biotechnology News | date = 5 April 2011 | accessdate = 21 December 2023}}</ref>

==References==
<references />


[[Category:Biotechnology companies of the United States]]
[[Category:Companies based in Birmingham, Alabama]]
[[Category:1996 establishments in Alabama]]


{{Med-company-stub}}